magyarcég
Egészségügy
Ipsen
  • Egészségügy

Ipsen

Global biopharmaceutical company developing transformative medicines in oncology, rare disease, and neuroscience.

  • Biopharmaceutical research and development
  • Development and sale of oncology treatments
  • Development and sale of rare disease treatments
  • Development and sale of neuroscience treatments
  • Sale of specialized pharmaceutical products

Bemutatkozás

Ipsen is a mid-sized global biopharmaceutical company with over 5,000 dedicated professionals worldwide. The company's origins trace back to the Beaufour Laboratories founded in Dreux, with Ipsen itself established as a subsidiary in 1975. Ipsen focuses on developing innovative treatments within three key therapeutic areas: oncology, rare disease, and neuroscience. Its detailed scope of services includes the research, development, and commercialization of a robust portfolio of medicines addressing high unmet medical needs.

Hivatalos adatok

Név, adószám, cégjegyzékszám, alapítás, létszám, legutolsó árbevétel és státusz – nyilvános webes forrásokból, néhány másodperc alatt.

Szolgáltatások, tevékenységek

  • Research and development of biopharmaceutical products
  • Development of oncology treatments
  • Development of rare disease treatments
  • Development of neuroscience treatments
  • Sale of Bylvay (odevixibat) for progressive familial intrahepatic cholestasis (PFIC)
  • Sale of Bylvay (odevixibat) for cholestatic pruritus in Alagille syndrome (ALGS)
  • Sale of Cabometyx (cabozantinib) for advanced kidney cancer (aRCC)
  • Sale of Cabometyx (cabozantinib) for liver cancer (hepatocellular carcinoma)
  • Sale of Cabometyx (cabozantinib) for differentiated thyroid carcinoma (DTC)
  • Sale of Cometriq for medullary thyroid cancer (MTC)
  • Sale of Decapeptyl (triptorelin pamoate or acetate) for prostate cancer
  • Sale of Decapeptyl (triptorelin pamoate or acetate) for endometriosis
  • Sale of Decapeptyl (triptorelin pamoate or acetate) for uterine fibroids
  • Sale of Decapeptyl (triptorelin pamoate or acetate) for central precocious puberty (CPP)
  • Sale of Decapeptyl (triptorelin pamoate or acetate) as adjuvant treatment for endocrine-responsive early-stage breast cancer
  • Provision of Decapeptyl (triptorelin pamoate or acetate) to induce ovulation for in vitro fertilization
  • Sale of Dysport (abobotulinumtoxinA) for focal spasticity of upper and lower limbs
  • Sale of Dysport (abobotulinumtoxinA) for spasmodic torticollis (cervical dystonia)
  • Sale of Dysport (abobotulinumtoxinA) for blepharospasm
  • Sale of Dysport (abobotulinumtoxinA) for hemifacial spasm
  • Sale of Dysport (abobotulinumtoxinA) for severe primary hyperhidrosis of the axillae
  • Sale of Dysport (abobotulinumtoxinA) for temporary improvement in appearance of moderate to severe glabellar and lateral canthal lines

Cégadatok

Cégnév
Ipsen Pharma
Székhely
65 Quai Georges Gorse 92100 Boulogne-Billancourt

A cégadatok a vállalkozás saját weboldalán közzétett impresszumból származnak.